Jitanan Laosiripisan1, Takashi Tarumi1, Mitzi M Gonzales2, Andreana P Haley2, Hirofumi Tanaka3. 1. Department of Kinesiology and Health Education, University of Texas at Austin, Austin, TX, 78712, USA. 2. Department of Psychology, University of Texas at Austin, Austin, TX, 78712, USA. 3. Department of Kinesiology and Health Education, University of Texas at Austin, Austin, TX, 78712, USA. htanaka@austin.utexas.edu.
Abstract
PURPOSE: A failure to control perfusion pressure due to impaired baroreflex sensitivity (BRS) could potentially cause chronic brain hypoperfusion, leading to cognitive dysfunction. The primary aim of this study was to determine whether BRS was associated with regional cerebral blood flow as measured by MRI arterial spin labeling (ASL) technique. METHODS: Baroreflex sensitivity was measured using the Valsalva maneuver technique in 52 middle-aged normotensive adults (49 ± 1 years), and phase IV of the Valsalva maneuver was used for analyses. Cerebral perfusion was measured using the ASL MRI technique in 10 pre-determined brain regions of interest. RESULTS: Hippocampal perfusion was correlated with BRS (R (2) = 0.17, P = 0.01). No association was observed between BRS and cerebral perfusion in the other brain regions of interest. Partial correlational analyses revealed that BRS was an important predictor of hippocampal perfusion, explaining 11 % of the variability independent of other covariates. When participants were divided into tertiles of BRS (11.8 ± 1.9 and 3.5 ± 0.1 ms/mmHg for the highest and lowest tertiles), regional cerebral perfusion of the hippocampus was significantly lower in the lowest BRS tertile than in the highest tertile (39.1 ± 4.3 and 60.5 ± 8.4 ml/100 g/min). CONCLUSIONS: Baroreflex sensitivity in midlife is positively associated with regional cerebral perfusion of the hippocampus, and impaired BRS appears to be related to brain hypoperfusion even in apparently healthy middle-aged adults. Future longitudinal studies based on the present cross-sectional findings may help to further define the relationship between BRS to cognitive dysfunction.
PURPOSE:A failure to control perfusion pressure due to impaired baroreflex sensitivity (BRS) could potentially cause chronic brain hypoperfusion, leading to cognitive dysfunction. The primary aim of this study was to determine whether BRS was associated with regional cerebral blood flow as measured by MRI arterial spin labeling (ASL) technique. METHODS: Baroreflex sensitivity was measured using the Valsalva maneuver technique in 52 middle-aged normotensive adults (49 ± 1 years), and phase IV of the Valsalva maneuver was used for analyses. Cerebral perfusion was measured using the ASL MRI technique in 10 pre-determined brain regions of interest. RESULTS: Hippocampal perfusion was correlated with BRS (R (2) = 0.17, P = 0.01). No association was observed between BRS and cerebral perfusion in the other brain regions of interest. Partial correlational analyses revealed that BRS was an important predictor of hippocampal perfusion, explaining 11 % of the variability independent of other covariates. When participants were divided into tertiles of BRS (11.8 ± 1.9 and 3.5 ± 0.1 ms/mmHg for the highest and lowest tertiles), regional cerebral perfusion of the hippocampus was significantly lower in the lowest BRS tertile than in the highest tertile (39.1 ± 4.3 and 60.5 ± 8.4 ml/100 g/min). CONCLUSIONS: Baroreflex sensitivity in midlife is positively associated with regional cerebral perfusion of the hippocampus, and impaired BRS appears to be related to brain hypoperfusion even in apparently healthy middle-aged adults. Future longitudinal studies based on the present cross-sectional findings may help to further define the relationship between BRS to cognitive dysfunction.
Authors: D Mungas; W J Jagust; B R Reed; J H Kramer; M W Weiner; N Schuff; D Norman; W J Mack; L Willis; H C Chui Journal: Neurology Date: 2001-12-26 Impact factor: 9.910
Authors: K D Monahan; F A Dinenno; D R Seals; C M Clevenger; C A Desouza; H Tanaka Journal: Am J Physiol Heart Circ Physiol Date: 2001-07 Impact factor: 4.733
Authors: I Skoog; B Lernfelt; S Landahl; B Palmertz; L A Andreasson; L Nilsson; G Persson; A Odén; A Svanborg Journal: Lancet Date: 1996-04-27 Impact factor: 79.321
Authors: P A Low; T L Opfer-Gehrking; B R McPhee; R D Fealey; E E Benarroch; C L Willner; G A Suarez; C J Proper; J A Felten; C A Huck Journal: Mayo Clin Proc Date: 1995-07 Impact factor: 7.616
Authors: Stephen J Roy; Brandon G Fico; Brett D Baker; Stephanie S Lapierre; Jay A Shah; Drew D Gourley; Laura A Delfausse; Hirofumi Tanaka Journal: Eur J Clin Nutr Date: 2019-04-25 Impact factor: 4.016
Authors: Hannah M Tayler; Jennifer C Palmer; Taya L Thomas; Patrick G Kehoe; Julian Fr Paton; Seth Love Journal: J Cereb Blood Flow Metab Date: 2017-08-07 Impact factor: 6.200
Authors: Frank J Wolters; Francesco U S Mattace-Raso; Peter J Koudstaal; Albert Hofman; M Arfan Ikram Journal: PLoS Med Date: 2016-10-11 Impact factor: 11.069